MAMarion Arce

Marion Arce

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marion Arce has a total of 56 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Combined Host‐Derived and Microbiological Biomarkers for the Detection of Peri‐Implant Bone Loss: A Diagnostic Accuracy Study

    by Marion Arce, Cristina Lima, Leire Virto, Juan Daniel Gamonal, Diogo Banaco, Mario Romandini, Mariano Sanz

    Aim: To evaluate the diagnostic accuracy of host‐derived and microbiological biomarkers, alone and in combination with clinical parameters, for the detection of peri‐implant bone loss (BL). Methods: A university‐based cohort of subjects with dental implants was examined at baseline and after a mean follow‐up of 3.9 years. Peri‐implant BL served as the reference standard, defined as > 1 mm between baseline and follow‐up radiographs; implants with < 0.5 mm BL served as controls. At follow‐up, peri‐implant crevicular fluid and submarginal‐microbiological samples were collected. Bone metabolism and inflammatory biomarkers were quantified using Luminex technology. Bacterial loads were quantified by qPCR. Associations of biomarkers with BL were evaluated using multilevel logistic regression models. Diagnostic accuracy was assessed using ROC curves, with AUC, sensitivity, specificity, and predictive values reported. Results: Seventy‐one subjects with 273 implants were included. Twenty‐eight exhibited peri‐implant‐BL > 1.0 mm over the follow‐up period. Increased levels of IL‐1β, T. denticola, Fusobacterium spp., and T. forsythia were associated with BL in unadjusted analyses. However, these associations were no longer statistically significant after adjustment for clinical parameters. Individual biomarkers demonstrated limited diagnostic accuracy (maximum AUC = 0.68). In contrast, biomarker combinations with clinical parameters exhibited excellent discriminative performance (AUC > 0.95). The combination of IL‐1β and BoP‐or‐PPD achieved the highest accuracy (AUC = 0.97). Conclusions: While individual biomarkers showed limited diagnostic utility, combining multiple predictors significantly improved the ability to detect peri‐implant BL. Combining IL‐1β with either BoP or PPD significantly outperformed individual clinical measures but did not outperform the combination of clinical parameters, highlighting the potential of integrated biomarker and clinical parameter approaches as screening tools for detecting BL.

  • Peri‐Implantitis‐Associated Bacteria Activate the STAT3 Pathway in Oral Epithelial Cells

    by Marion Arce, Joaquin Espinoza‐Arrue, Daniel Sansores‐España, Matias Morales, Mauricio J. Farfan, Mariano Sanz, Loreto Abusleme, Nicolas Dutzan

    Aim: To assess STAT3 activation in peri‐implantitis tissues and to evaluate the STAT3‐associated response of oral epithelial cells (OECs) to peri‐implantitis‐associated bacteria. Methods: In this cross‐sectional study, gingival tissue biopsies were obtained from subjects with gingival health, periodontitis and peri‐implantitis. pSTAT3/STAT3 and STAT3 pathway‐dependent mRNA levels were analysed, and pSTAT3‐positive cells were assessed by immunofluorescence. Additionally, OECs were stimulated with S. sanguinis , P. gingivalis and F. nucleatum , as well as with bacterial communities from the three conditions. STAT3 pathway–associated mRNA levels and the pSTAT3/STAT3 ratio were evaluated. Finally, the effect of pSTAT3 inhibition was analysed. Results: Increased STAT3 pathway activation was observed in peri‐implantitis tissues, characterised by a higher pSTAT3/STAT3 ratio and elevated IL6 and SOCS3 mRNA levels. Compared with healthy gingival tissues and periodontitis, peri‐implantitis tissues exhibit a higher proportion of pSTAT3‐positive epithelial cells. P. gingivalis and F. nucleatum increased the mRNA of the STAT3‐associated IL6 , IL23A , SOCS3 , chemoattractant‐associated CXCL8 , IL36G and inflammation‐associated IL1B , TNF A. Notably, STAT3 inhibition decreased the mRNA levels of STAT3‐downstream cytokines and the neutrophil chemoattractants CXCL8 and IL36G . Conclusion: The STAT3 pathway is activated in peri‐implantitis and in OECs and is elicited by peri‐implantitis‐associated bacteria, contributing to a pro‐chemotactic epithelial environment, positioning this pathway as a key area of interest for future research into the molecular mechanisms underlying both conditions.

  • Open Access

    “A decrease in specific health-associated commensals is linked to progressive periodontal tissue destruction independent of dysbiotic community profiles”

    by Natalia Endo, Joaquin Espinoza-Arrue, Marion Arce, Nicole Traver, Maria I. Muñoz-Sepúlveda, Daniel Sansores-España, Valentina Olmedo, Catalina Moreno, Javiera Canelo, Montserrat Reyes, et al.

    Periodontitis is a chronic inflammatory disease associated with dysbiotic microbial communities that leads to destruction of the tooth-supporting tissues. The transition from host-microbial periodontal homeostasis to disease remains poorly understood. The murine ligature-induced periodontitis model was employed to characterize the temporal dynamics of the subgingival microbiome and host tissue features. Ligatures were placed in C57BL/6N mice, and collected on days 0, 1, 3, 5, and 7 post-induction. Bacterial load, alveolar bone loss, immune cells (CD45⁺), cells with osteoclastogenic potential (TRAP⁺) and collagen destruction were analyzed. Additionally, the V4 region of the 16S rRNA gene was sequenced for ecological analyses, including co-occurrence networks and functional prediction. Spatial distribution of the most abundant species was visualized using CLASI-FISH microscopy. Finally, association models were performed to link bacterial abundances with time and tissue parameters. The most substantial microbial shift occurred on day 1, and a dysbiotic community was established by day 3. CD45⁺ cell infiltration increased as early as day 1, preceding the rise in TRAP⁺ cells on day 3 and the onset of tissue destruction on day 5. By day 7, predicted bacterial functions included protein export, lipid and galactose metabolism. Health-associated taxa were identified, and their abundance correlated positively with collagen integrity and negatively with immune cell infiltration and bacterial load, highlighting their role in homeostasis. These findings provide a high-resolution temporal map of microbiome-host interactions during experimental periodontitis establishment and identify specific microbial and cellular windows for potential therapeutic intervention.

  • Management of Necrotising Periodontal Diseases: A Systematic Review

    by Eduardo Montero, Nerea Sánchez, Evangelia P. Zampa, Bettina Alonso, Marion Arce, Phoebus Madianos

    Aim: To evaluate the efficacy of interventions for treating necrotising periodontal diseases (NPDs), including the management of the acute condition and subsequent therapies targeting sequelae and/or predisposing factors. Methods: Following PRISMA guidelines, electronic and manual searches were conducted up to April 2025. Randomised controlled trials (RCTs), controlled clinical trials (CCTs) and case series assessing any therapeutic intervention for NPDs (separating them for acute disease resolution and treatment of the preexisting condition and/or management of sequelae) were included. Results: Thirty‐five studies were included (18 RCTs, 2 CCTs, 15 case series). Mechanical debridement combined with antiseptic rinses (e.g., chlorhexidine or hydrogen peroxide) constitutes the primary therapeutic approach. Systemic antimicrobials, mainly metronidazole, have also frequently been evaluated and used as adjuncts or monotherapy. Reduced pain, bleeding and ulcer resolution within days were the common findings for all tested interventions. Recent trials explored photodynamic therapy (PDT) as adjuncts, showing short‐term clinical and microbiological benefits. Evidence was heterogeneous and of high risk of bias. Only five studies addressed post‐acute management, with none of them investigating reconstructive approaches or long‐term recurrence prevention. Conclusions: Management of NPDs relies primarily on mechanical debridement and antiseptics, with systemic antimicrobials reserved for cases with systemic involvement. Adjunctive modalities such as PDT have shown promising results but require further validation. Evidence on reconstructive approaches and recurrence prevention is lacking.


  • Top Cited Papers

    Longitudinal Changes in the Peri‐Implant Microbiome Following Implant Placement: A 3‐Year Follow‐Up Study

    by Blanca Vílchez, Cristina Chamorro, Elena Figuero, María José Marín, Marion Arce, Purnima S. Kumar, Mariano Sanz

    Aim: To investigate longitudinal changes in the submucosal peri‐implant microbiome during early healing and long‐term maturation, and their association with clinical and radiographic outcomes. Materials and Methods: This is the 3‐year follow‐up of a subset of individuals from a randomized controlled clinical trial. Marginal bone level changes (MBL) were measured at implant placement, loading, 12 months, and 3 years; clinical parameters were recorded at 12 months and 3 years. Submucosal plaque samples were collected at 1 week, 4 weeks, and 3 years post‐implantation and analyzed by 16S rRNA gene sequencing. Microbial diversity, composition, and co‐occurrence networks were evaluated. Results: Twenty‐seven patients (64 implants) completed the 3‐year visit. At 3 years, peri‐implant clinical conditions and MBL remained stable across visits, although early supracrestal remodeling was observed. The incidence of peri‐implant mucositis was 14.8% and peri‐implantitis 11.1% at patient‐level. Microbiome richness and phylogenetic diversity increased over time ( p < 0.0001). Early biofilms were dominated by facultative anaerobes (e.g., Haemophilus parainfluenzae , Neisseria elongata ), which declined at 3 years, when anaerobic/proteolytic taxa (e.g., Prevotella , Porphyromonas gingivalis , Fusobacterium nucleatum ) became more prominent. Presence/absence analyses at 3 years showed persistence of early colonizers alongside the integration of later‐arriving species. Lactococcus lactis and Enterococcus italicus increased in abundance and occupied more central positions in co‐occurrence networks. Conclusions: Over 3 years, the peri‐implant microbiome matured into a more diverse and structured community, while MBL remained stable with physiological early supracrestal remodeling. These longitudinal findings suggest that early colonization and its subsequent evolution may influence long‐term peri‐implant health.


  • Top Cited Papers
    Open Access

    Inflammatory and Immunological Basis of Periodontal Diseases

    by Giacomo Baima, Marion Arce, Mario Romandini, Thomas Van Dyke

    In its most common form, periodontitis is viewed as a chronic immunoinflammatory disorder of the tooth supporting tissues, shaped by host–microbiome disequilibrium, exaggerated immune activation, and impaired resolution mechanisms. This review explores the periodontal battlefield through its inflammatory and immunological lens, beginning with the transformation of the lesion from silent immune surveillance to sustained inflammation, connective tissue degradation, and alveolar bone loss. The classical Page and Schroeder model is used as a foundation but reinterpreted in light of current evidence derived from advanced molecular techniques. The immunological architecture is subsequently dissected through the involvement of its principal cellular players, acting in a dynamic battleground composed of saliva, crevicular fluid, epithelial barriers, and connective tissues. On the frontlines, neutrophils act as double‐edged defenders, capable of both microbial clearance and bystander tissue damage. Like macrophages and dendritic cells, they also serve as strategic sensors and shapers of immunity, bridging innate and adaptive responses. Among these, the T cell arsenal includes inflammatory subsets such as Th1, Th17, and cytotoxic cells, balanced by regulatory T cells. B lymphocytes and plasma cells emerge not only as antibody producers but also as pro‐inflammatory effectors, with growing evidence implicating autoreactive subsets in tissue damage, particularly in aggressive forms of the disease. Equally critical are the structural cells: gingival fibroblasts, which transition from matrix architects to immune‐active contributors under stress, and osteocytes, recognized as mechanosensitive regulators of bone turnover and immune signaling. Alongside osteoblasts and osteoclasts, these elements form a fragile yet responsive osteoimmune axis that determines the trajectory toward either tissue homeostasis or destruction. The molecular arsenal fueling this conflict—cytokines, chemokines, complement, specialized pro‐resolving mediators, neuropeptides, and matrix metalloproteinases—is also examined, highlighting how its dysregulation sustains chronic inflammation and drives structural breakdown. The review also explores how this localized immune conflict echoes systemically, contributing to broader immune activation and comorbidity. By reframing periodontitis as a prototypical immune‐mediated disease, this work contributes to a deeper understanding of its pathogenesis and provides a framework for future research aimed at disentangling its immunological complexity and clinical heterogeneity for targeted diagnostic strategies and immune‐based therapeutics.


  • Profiling the Bacterial Microbiome Across Peri‐Implant Conditions

    by Joaquin Espinoza‐Arrue, Marion Arce, Natalia Endo, Anilei Hoare, Nicolas Dutzan, Loreto Abusleme

    Aim: To comprehensively characterise the bacterial microbiome in peri‐implant health, peri‐implant mucositis and peri‐implantitis. Materials and Methods: A re‐analysis of raw microbiome data was performed from 15 studies, which were finally selected based on the availability of 16S rRNA sequencing. Reads were pre‐processed using mothur and classified using the HOMD database. A total of 522 samples were analysed to evaluate diversity estimates and bacterial relative abundance, identifying discriminant features via LEfSe, while predictions of functional potential were obtained using PICRUSt2. Bacterial co‐occurrence networks were constructed, and dysbiosis was measured by employing the subgingival microbiome dysbiosis index. Results: Peri‐implantitis showed higher bacterial diversity compared to health and greater microbial richness than peri‐mucositis. Each clinical condition displayed a distinct community structure and bacterial co‐occurrence networks. The representative species in peri‐implant health were Rothia aeria , R. dentocariosa and Veillonella parvula_dispar . Peri‐mucositis is characterised by Leptotrichia hongkongensis , L. wadei and Fusobacterium nucleatum subsp. polymorphum , while peri‐implantitis is defined by Porphyromonas gingivalis , F. nucleatum subsp. vincentii and Tannerella forsythia . Peri‐implantitis exhibited enrichment in predicted microbial pathogenesis pathways and greater bacterial dysbiosis. Conclusions: These results provide deeper insights into the peri‐implant microbiome, identifying key bacterial species, functional processes and interactions that may be crucial to inflammation and destruction during peri‐implant diseases.


  • Open Access

    The Effect of Xanthohumol and Thymol on Candida albicans Filamentation and Its Impact on the Structure, Size, and Cell Viability of Biofilms Developed over Implant Surfaces

    by Enrique Bravo, Marion Arce, David Herrera, Mariano Sanz

    The aim of this in vitro study was to evaluate the effect of xanthohumol and thymol on the impact of Candida albicans on the structure, size and cell viability of subgingival biofilms formed on dental implant surfaces. The structure and microbial biomass of biofilms developed after 72 h, treated and untreated with both extracts, were compared by scanning electron microscopy (SEM) and confocal laser microscopy (CLSM). Quantitative polymerase chain reaction (qPCR) was used to quantify the number of viable and total microorganisms of each of the biofilm-forming strains in each condition. A general linear model was used to compare and validate the CLSM and qPCR results. The presence of xanthohumol and thymol during biofilm development inhibited the filamentous growth of C. albicans. The biofilm incubated with xanthohumol had significantly lower bacterial biomass and cell viability than the biofilm not exposed to the extract (p < 0.05). In contrast, these global parameters showed no differences when the biofilm was incubated with thymol. In the presence of xanthohumol, there was a decrease in counts and cell viability of Fusobacterium nucleatum, Porphyromonas gingivalis, and Aggregatibacter actinomycetemcomitans. Thymol treatment reduced the viability of F. nucleatum and P. gingivalis. The presence of these vegetable extracts during the development of a dynamic in vitro multispecies biofilm model inhibited the filamentous growth of C. albicans, partially reversing the effect that the fungus exerted on the structure, size and vitality of periodontopathogenic bacteria.


  • Open Access

    The Impact of Candida albicans in the Development, Kinetics, Structure, and Cell Viability of Biofilms on Implant Surfaces—An In Vitro Study with a Validated Multispecies Biofilm Model

    by Enrique Bravo, Marion Arce, Honorato Ribeiro-Vidal, David Herrera, Mariano Sanz

    This study aimed to evaluate the impact of Candida albicans on subgingival biofilm formation on dental implant surfaces. Scanning electron microscopy (SEM) and confocal laser scanning microscopy (CLSM) were used to compare biofilm structure and microbial biomass in the presence and absence of the fungus after periods of 24, 48, and 72 h. Quantitative polymerase chain reaction (qPCR) was used to quantify the number of viable and total micro-organisms for each of the biofilm-forming strains. A general linear model was applied to compare CLSM and qPCR results between the control and test conditions. The biofilm developed with C. albicans at 72 h had a higher bacterial biomass and a significantly higher cell viability (p < 0.05). After both 48 and 72 h of incubation, in the presence of C. albicans, there was a significant increase in counts of Fusobacterium nucleatum and Porphyromonas gingivalis and in the cell viability of Streptococcus oralis, Aggregatibacter actinomycetemcomitans, F. nucleatum, and P. gingivalis. Using a dynamic in vitro multispecies biofilm model, C. albicans exacerbated the development of the biofilm grown on dental implant surfaces, significantly increasing the number and cell viability of periodontal bacteria.


  • Open Access

    The Impact of Candida albicans in the Development, Kinetics, Structure, and Cell Viability of Biofilms on Implant Surfaces. An In Vitro Study with a Validated Multispecies Biofilm Model

    by Enrique Bravo, Marion Arce, Honorato Ribeiro-Vidal, David Herrera, Mariano Sanz

    This study aimed to evaluate the impact of Candida albicans on subgingival biofilm formation on dental implant surfaces. Scanning electron microscopy (SEM) and confocal laser scanning microscopy (CLSM) were used to compare biofilm structure and microbial biomass in the presence and absence of the fungus after periods of 24, 48, and 72 h. Quantitative polymerase chain reaction (qPCR) was used to quantify the number of viable and total micro-organisms for each of the biofilm-forming strains. A general linear model was applied to compare CLSM and qPCR results between control and test conditions. The biofilm developed with C. albicans at 72 h had a higher bacterial biomass, with a significantly higher cell viability (p < 0.05). After both 48 and 72 h of incubation, in the presence of C. albicans, there was a significant increase in counts of Fusobacterium nucleatum and Porphyromonas gingivalis and in the cell viability of Streptococcus oralis, Aggregatibacter actinomycetemcomitans, F. nucleatum, and P. gingivalis. Using a dynamic in vitro multispecies biofilm model, C. albicans exacerbated the development of the biofilm grown on dental implant surfaces, significantly increasing the number and cell viability of periodontal bacteria.